Several groups have reported that mice with targeted deletions in the genes for MCP-1/CCL2 and its receptor CCR2 have reduced adipose tissue macrophage (ATM) content, decreased inflammation in fat and protection from high-fat (HF) diet-induced insulin resistance (15). Here, CCL2 is linked to Insulin resistance.